David Newble joins TTP Labtech as new managing director

22-Jun-2015 - United Kingdom

TTP Labtech announced the appointment of David Newble as its new managing director. Dr. Jas Sangera, founder, managing director and key driver for the company for the last 14 years, will continue his role as the company’s chairman.

David Newble has a proven track record of growing life sciences companies and bringing new technologies and products to the market and is therefore well placed to lead continued growth at TTP Labtech. He was previously chief executive officer (CEO) at TAP Biosystems (now part of Sartorius Stedim Biotech Group), a leading provider of automated cell culture and fermentation systems. During David’s time as CEO, TAP developed and launched a range of small scale automated bioreactors, growing its cell culture business four-fold as a result.

Over the last 14 years TTP Labtech has grown from The Technology Partnership’s (TTP’s) consultancy business to become a global leader in the field of life science automation and instrumentation. David’s appointment will enable TTP Labtech to further strengthen its market position by launching more products and expanding into new application areas.

Other news from the department people

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics